ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search
  • 2015 American Transplant Congress

    Clinical Impact of 18F-FDG-PET/CT in Living Donor Liver Transplantation for Advanced Hepatocellular Carcinoma

    S. Lee, S. Kim.

    Liver Cancer Center, National Cancer Center, Goyang, Korea.

    Background: The relevant number of patients with hepatocellular carcinoma (HCC) beyond the Milan criteria has undergone living donor liver transplantation (LDLT). However, the prognostic factors…
  • 2015 American Transplant Congress

    Eosinophilic Gastrointestinal Disease in Pediatric Liver and Kidney Transplant Recipients

    S. Mohammad,1 J. Bush,2 K. Amsden,1 A. Kagalwalla,1 H. Melin-Aldana,2 N. Arva.2

    1Pediatrics, Northwestern University, Chicago; 2Pathology, Northwestern University, Chicago.

    Eosinophilic gastrointestinal disease (EGID) has been associated with immunosuppression use in solid organ transplant recipients. However, its relationship to the post-transplant clinical course is unknown.…
  • 2015 American Transplant Congress

    Is There a Difference in Patient and Graft Survival in Children Weighing <20 kg Versus Those Weighing >20 kg at the Time of Renal Transplantation?

    P. Chandak,1 J. Stojanovic,2 R. Sivaprakasam,3 N. Mamode,1 F. Calder,1 J. Olsburgh,1 M. Drage,1 C. Callaghan,1 J. Taylor,1 G. Koffman,1 J. Taylor,2 S. Marks,4 N. Kessaris.1

    1Transplant Surgery, Guys and St Thomas Hospitals NHS Trust, London, United Kingdom; 2Nephrology, Evelina Childrens Hospital, London, United Kingdom; 3Transplant Surgery, Royal London Hospital, London, United Kingdom; 4Department of Nephrology and Transplantation, Great Ormond Street Hospital for Children, London, United Kingdom.

    Introduction: Renal transplantation (RTx) is the gold standard treatment modality for end-stage kidney disease. There are increased challenges in pediatric renal transplant recipients (pRTR) under…
  • 2015 American Transplant Congress

    Rituximab: Summarizing the Intracacies of the Black Box Warning and Expenses in Transplantation

    N. Jandovitz, J. Lee, M. Bezman, D. Tsapepas.

    Department of Pharmacy, NewYork-Presbyterian Hospital, New York, NY.

    Post-transplant use of rituximab has become common, yet is associated with significant safety concerns and cost. Hepatitis B virus (HBV) reactivation following rituximab therapy poses…
  • 2015 American Transplant Congress

    Long-Term Results After Heart Transplantation – A Randomized Trial Comparing Tacrolimus Versus Cyclosporine A in Combination With Mycophenolate Mofetil After a Mean Duration of 15 Years

    S. Guethoff,1 C. Grinninger,1 B. Reichart,2 P. Ueberfuhr,1 C. Hagl,1 B. Meiser.2

    1Department of Cardiac Surgery, Ludwig-Maximilians University, Munich, Germany; 2Transplantation Center, Ludwig-Maximilians University, Munich, Germany.

    Purpose. Development of cardiac allograft vasculopathy (CAV), renal dysfunction and malignancies are the main risks due to long-term immunosuppressive therapy after heart transplantation (HTx). We…
  • 2015 American Transplant Congress

    Low Dose Valganciclovir Prophylaxis Following Renal Transplantation With Steroid Free Immunosuppression

    J. Chen,1 A. Shah,2 M. Sauer,1 T. Taber,3 A. Sharfuddin,3 M. Yaqub,3 D. Mishler,3 J. Powelson,4 W. Goggins.4

    1Pharmacy, IU Health, Indianapolis; 2Surgery, Thomas Jefferson University, Philadelphia; 3Nephrology, Indiana University School of Medicine, Indianapolis; 4Surgery, Indiana University School of Medicine, Indianapolis.

    AST ID guidelines recommend a valganciclovir (VGCV) prophylaxis dose of 900 mg daily for patients with CrCL > 60 mL/min with reduced dose for renal…
  • 2015 American Transplant Congress

    Utilization of Medicare Part D Among Transplant Recipients

    M. Chisholm-Burns, C. Spivey.

    University of Tennessee College of Pharmacy, Memphis, TN.

    Purpose: As cost is a critical barrier to medication access among transplant recipients, Medicare Part D represents a key strategy in medication acquisition. Due to…
  • 2015 American Transplant Congress

    Remote Ischemic Preconditioning Increases Transplantation of Abdominal Organs in Standard Criteria Neurological Death Donors

    A. Bongu,1 W. Washburn,2 J. Oliver,1 J. Nespral,3 A. Davidow,4 C. Kadric,3 G. Dikdan,1 J. Lewis,2 U. Pandit,1 A.-K. Beidas,1 C. Tourtellot,3 L. Brown,1 B. Koneru.1

    1Surgery, Rutgers-New Jersey Medical School, Newark, NJ; 2Surgery, University of Texas Health Science Center, San Antonio, TX; 3Texas Organ Sharing Alliance, San Antonio, TX; 4Preventive Medicine, Rutgers-New Jersey Medical School, Newark, NJ.

    Background: Remote ischemic preconditioning (RIPC) induces innate protective mechanisms in remote organs. We hypothesized RIPC soon after neurological death (ND) would improve donor organ function…
  • 2015 American Transplant Congress

    Is Electron Microscopy Adding a Diagnostic Advantage in the Evaluation of Renal Allograft Biopsies for Antibody Mediated Rejection (AMR)?

    J. Papadimitriou, M. Chaudhry, C. Drachenberg, R. Ugarte, D. Klassen, E. Ramos, C. Cangro, B. Thomas, M. Mavanur, A. Haririan.

    Pathology and Medicine, University of Maryland School of Medicine, Baltimore, MD.

    Some electron microscopy (EM) findings have been consistently associated with antibody mediated microvascular injury; however, no large studies have been performed examining the concrete advantage…
  • 2015 American Transplant Congress

    Domino Liver Transplant from Donors With MSUD: Operative Strategy and Long-Term Outcomes

    B. Kelly,1 K. Soltys,1 G. Bond,1 J. Vockley,2 K. Strauss,3 H. Morton,3 R. Sindhi,1 G. Mazariegos.1

    1Surgery, Hillman Center for Pediatric Transplantation, Children's Hospital Pittsburgh, Pittsburgh, PA; 2Pediatric Genetics, Children's Hospital Pittsburgh, Pittsburgh, PA; 3Pediatrics, Clinic for Special Children, Pittsburgh, PA.

    Liver transplant (txp) is the definitive branched chain keto-acid (BCKA) replacement therapy for patients with Maple Syrup Urine Disease (MSUD). Due to the extra-hepatic distribution…
  • « Previous Page
  • 1
  • …
  • 130
  • 131
  • 132
  • 133
  • 134
  • …
  • 170
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences